Ceftazidime–Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients

INTRODUCTION: The aim of the present study was to assess the safety profile and outcomes of a ceftazidime–avibactam (CAZ-AVI)-based regimen and compare them with those of a tigecycline (TGC)-based regimen in intensive care unit (ICU) for the treatment of carbapenem-resistant Klebsiella pneumoniae (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ying, Hu, Jing, Liu, Peiben, Wang, Tingting, Wang, Han, Liu, Yun, Cao, Quan, Zuo, Xiangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517067/
https://www.ncbi.nlm.nih.gov/pubmed/34652713
http://dx.doi.org/10.1007/s40121-021-00542-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517067/
https://www.ncbi.nlm.nih.gov/pubmed/34652713
http://dx.doi.org/10.1007/s40121-021-00542-3

Ejemplares similares